PTAB Upholds Patent For Akorn Glaucoma Drug Zioptan
The Patent Trial and Appeal Board has upheld a patent covering Akorn Inc.'s glaucoma medication Zioptan, following an inter partes review in which the board pressed forward despite the challenger backing...To view the full article, register now.
Already a subscriber? Click here to view full article